Antibiotics

It is produced by the strain of Trichoderma harzianum. It has weak anti-gram-positive bacterial activity and anti-tumor effect, it can inhibit lymphoblastic leukemia L1210 and leukemia P388 with IC50 of 0.26 μg/mL. It inhibits the binding of viral particle regulatory (REV) proteins to [33P] labeled viral particle regulatory effector element (RRE) RNA, IC50 is 2.0 μmol/L. 200 μg/mL of Harziphilone does not protect CEM-SS cells from HIV-1 infection, and 38μmol/L of Harziphilone has cytotoxicity to mouse tumor cells M-109.

It is produced by the strain of Saccharopolyspora YL-0358M. It is an alkaloid antibiotic. It has weaker activity against gram-positive bacteria. It also shows cytotoxicity to lymphocytic leukemia L1210 and leukemia P388 cells.

It is produced by the strain of Streptomyces sp. 2238-SVT4. It can enhance the effect of Colchicines against multidrug resistance (MDR) tumor cells.

It is produced by the strain of Streptomyces sp. 2238-SVT4. It can enhance the effect of Colchicines against multidrug resistance (MDR) tumor cells.

It is produced by the strain of Streptomyces sp. 2238-SVT4. It can enhance the effect of Colchicines against multidrug resistance (MDR) tumor cells.

It is produced by the strain of Streptomyces sp. 2238-SVT4. It can enhance the effect of Colchicines against multidrug resistance (MDR) tumor cells.

It is produced by the strain of Pseudomonas sp. SCC 1411 or Micromonospora echinospora var challisensis SCC 1411. It has weak activity against gram-negative bacteria, yeast and skin fungi.

It is produced by the strain of Pseudomonas sp. SCC 1411 or Micromonospora echinospora var challisensis SCC 1411. It has weak activity against gram-negative bacteria, yeast and skin fungi.

It is produced by the strain of Mycogone rosea DSM 8822. It is a lipopeptide antifungal antibiotic. It has anti-candida albicans, gram-positive bacteria, mycobacterium activity with MIC of 1.5-5.0 μg/mL.

It is produced by the strain of Mycogone rosea DSM 8822. It is a lipopeptide antifungal antibiotic. It has anti-candida albicans, gram-positive bacteria, mycobacterium activity with MIC of 1.5-5.0 μg/mL.

It is produced by the strain of Pseudonocardia compacta subsp. Helvetica SANK 65185. It is a glycopeptidtic antibiotic. It has strong activity of anti-aerobic and anaerobic gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, but its protective effect against staphylococcus aureus infection in mice is lower than vancomycin.

It is produced by the strain of Pseudonocardia compacta subsp. Helvetica SANK 65185. It is a glycopeptidtic antibiotic. It has strong activity of anti-aerobic and anaerobic gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, but its protective effect against staphylococcus aureus infection in mice is lower than vancomycin.

It is produced by the strain of Cephalosporium caerulens. It is a steroidal antibiotic. It has anti-gram-positive bacterial activity.

It is produced by the strain of Cephalosporium caerulens. It is a steroidal antibiotic. It has anti-gram-positive bacterial activity.

It is produced by the strain of Streptomyces filipinensis MA-4581 (NRRL 11044). It has anti-gram-positive bacteria, negative bacteria and mycoplasma activities, and has the effect of promoting animal growth.

It is produced by the strain of Emericellopsis sp. BAUA8289. It is a peptaibol antifungal antibiotic. It has the activity against gram-positive bacteria (MIC is 8 μg/mL) such as Staphylococcus aureus and fungi (MIC is 13-32 μg/mL) such as Aspergillus, Candida albicans and cryptococcus neofordii, and it has moderate anti-Rhabditella pseudoelongata activity (MIC is 50 μg/mL).

It is produced by the strain of Streptomyces saganoensis. It has herbicidal and anti-gram-positive bacterial activity.

It is produced by the strain of Streptomyces hygroscopicus. It is an ansamycin antibiotic that acts as a Src family kinase inhibitor. It has herbicidal effect on most monocotyledons and dicotyledons, inhibits the activity of tobacco Mosaic virus (TMV), HeLa cells and Ehrlich cells.

11-Deoxydoxorubicin is an impurity of Doxorubicin, which is an anthracycline antibiotic with anti-Gram-positive bacterial activity and a broad antitumor spectrum.

It is produced by the strain of Streptomyces roseofulvus AM-3867. Deoxyfrenolicin has the ability of anti-fungal and mycoplasma.